A5027884586- Hemophilia Treatment and Research
- Tuberculosis Research and Epidemiology
- Maternal and fetal healthcare
- Platelet Disorders and Treatments
- Emergency and Acute Care Studies
- Pharmaceutical Economics and Policy
- Infectious Diseases and Tuberculosis
- Trauma and Emergency Care Studies
- Ultrasound in Clinical Applications
- Autoimmune Bullous Skin Diseases
- Diverse Perspectives in Modern Studies
- Diagnosis and treatment of tuberculosis
Canadian Hemophilia Society
2023
Riga Stradiņš University
2017-2020
Objectives: Pediatric mortality in Latvia remains one of the highest among Europe. The purpose this study was to assess quality pediatric acute care and readiness determine their association with patient outcomes using a registry. Design: This prospective cohort study. measured weighted score based on 100-point scale. processes were situ simulations generate composite score. Clinical outcome data—including PICU hospital length stay as well 6-month mortality—were collected from Intensive Care...
To perform a comprehensive analysis of case detection, diagnosis and treatment tuberculosis (TB) in children adolescents Latvia, to evaluate the utility current approach.A retrospective study all Latvian diagnosed with TB from 1 January 2011 31 December 2014.Of 3081 patients during 2011-2014, 250 (8%) were aged <18 years, 80% identified through contact investigation. Pulmonary was 77% patients. confirmed bacteriologically 21% patients; chest X-ray (CXR) consistent 42% participants, while 58%...
Recent guidelines for von Willebrand Disease (VWD) highlighted the challenges in diagnosis and management. Identifying number of persons with VWD (PwVWD) internationally will help target support to aid PwVWD.To examine international registration rates PwVWD, influence income status, geographical region age sex profile. Cumulatively, these data be used inform future strategy from World Federation Haemophilia (WFH) address unmet clinical research needs.Data 2018/2019 WFH Annual Global Survey...
Introduction Adherence to prophylactic treatment is a critical factor in the management of haemophilia, impacting patient outcomes. Prophylactic not only reduces bleeding episodes but also prevents debilitating haemarthropathy. Reported adherence rates vary widely across countries, ranging from 4.1% 94.2% [1] [2] [3] [4] [5], highlighting importance haemophilia care. Higher has consistently been linked improved clinical outcomes, especially severe haemophilia. We employed VERITAS-Pro method...
Abstract Figures in the World Federation of Hemophilia (WFH) global annual survey indicate, by their absence, that there is under-recognition bleeding disorders women. The WFH and its national member organisations (NMOs) are working to raise awareness improve diagnosis care women with globally, regionally locally. initiatives include a programme focused on improving diagnosis, treatment von Willebrand disease (VWD), programmes involving education training conjunction NMOs countries including...